India Tightens Clinical Trial Oversight
Global regulatory news tracker RegLink weighs in on India's new drug and device clinical trial rules
(PRWeb August 09, 2012)
Read the full story at http://www.prweb.com/releases/2012/8/prweb9783934.htm
Global regulatory news tracker RegLink weighs in on India's new drug and device clinical trial rules
(PRWeb August 09, 2012)
Read the full story at http://www.prweb.com/releases/2012/8/prweb9783934.htm
Global regulatory news tracker RegLink weighs in on India's new drug and device clinical trial rules
(PRWeb August 09, 2012)
Read the full story at http://www.prweb.com/releases/2012/8/prweb9783934.htm
Global regulatory news tracker RegLink weighs in on India's new drug and device clinical trial rules
(PRWeb August 09, 2012)
Read the full story at http://www.prweb.com/releases/2012/8/prweb9783934.htm
Yali Friedman lives in Washington, DC and is author of Building Biotechnology and other books; founder of DrugPatentWatch; and chief editor of the Journal of Commercial Biotechnology.
